26
7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 1/26 Medication-Induced Anaphylactic Hypersensitivity: A  Concept Mapping Presented by:  A. Enriquez, RN  A. Martin, RN H. de Guzman, RN L. Roaquin, RN T. Cui, RN

Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

Embed Size (px)

Citation preview

Page 1: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 1/26

Medication-Induced Anaphylactic

Hypersensitivity:

A Concept Mapping

Presented by:

 A. Enriquez, RN

 A. Martin, RN

H. de Guzman, RN

L. Roaquin, RN

T. Cui, RN

Page 2: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 2/26

Anaphylactic Hypersensitivity

• Most severe form of hypersensitivity 

•  Acute systemic hypersensitivity reaction thatoccurs within seconds or minutes after exposureto certain foreign substances.

• Result of an antigen-antibody interaction in a

sensitized individual who has developed aspecial type of immunoglobulin that is specificfor that allergen

• IgE is responsible for most of the immediate

type of human allergic responses

Page 3: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 3/26

Anaphylactic Hypersensitivity

• Mr. E is a 37 y/o male who presents to thehospital at 9:08am

•  With complaints of severe abdominal cramping,n/v, dizziness, tingling and numbness of extremities.

•  As reported, he took ibuprofen for muscularpain after shift that day 

Page 4: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 4/26

Anaphylactic Hypersensitivity

•  According to the patient, it was his first time totake ibuprofen since he used to take paracetamolfor pain management.

• He was diagnosed to have HTN 2 years ago.

• Complies with the therapeutic regimen but do

not regularly take his medicine due to busy schedule

•  Asthma is common in their bloodline

Page 5: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 5/26

Assessment:

• Upon admission, there was complaint of chestpain, throat tightness, dyspnea, tingling &

 warmth sensation, odynophagia, altered mentalstatus but conversant,

• BP: 80/50, PR: 125, RR: 24, afebrile uponadmission, (+) angioedema & lacrimation, with

conjunctival injection, presence of nasal flaring,stridor upon auscultation, diffuse abdominaltenderness upon palpation, and generalizedurticaria

Page 6: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 6/26

Diagnostic Workup:

• IgE = 626 U/mL

• Histamine (U) = 495 nmol/g crt

Page 7: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 7/26

Case Study

• Mr. E is a 37 y/o single male

• c/o of throat tightness

• Hx: HTN, asthma

• Used to smoke (6 years ago) and drinksoccasionally (1-3 bottles a week)

• Uses paracetamol for muscle pain; first to takeibuprofen

Page 8: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 8/26

Case Study

• Other S/sx included are generalized urticaria,altered mental status, dyspnea, chest tightness,abdominal cramping and n/v 

Page 9: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 9/26

Risk Factors

Exposure to antigen(ibuprofen)

Hereditary (Hx of Asthma)

Page 10: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 10/26

Pathophysiology

Exposure to antigen(ibuprofen)

Hereditary (Hx of Asthma)

Release of inflammatory mediators

Page 11: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 11/26

Diagnosis/Presenting Problem

Exposure to antigen(ibuprofen)

Hereditary (Hx of Asthma)

Release of inflammatory mediators

Medication-Induced Anaphylactic Reaction

Page 12: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 12/26

Assessment Findings

Exposure to antigen(ibuprofen)

Hereditary (Hx of Asthma)

Release of inflammatory mediators

Medication-Induced Anaphylactic Reaction

Smooth MuscleContraction

 Vasodilation

Inc. vascularPermeability 

Integumentary S/Sx

Rhinnorhea

Page 13: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 13/26

Diagnostic Procedure

Exposure to antigen(ibuprofen)

Hereditary (Hx of Asthma)

Release of inflammatory mediators

Medication-Induced Anaphylactic Reaction

Smooth MuscleContraction

 Vasodilation

Inc. vascularPermeability 

Integumentary S/Sx

Rhinnorhea

IgE = 626 U/mL

Histamine = 495

nmol/g CRT

Page 14: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 14/26

MedicationsSmooth Muscle

Contraction Vasodilation

Inc. vascularPermeability 

Integumentary S/Sx

O2 administrationranitidine

epinephrine0.9% NaCl IV  methylprednisolone diphenhydramine

Page 15: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 15/26

Nursing DiagnosisSmooth Muscle

ContractionSmooth Muscle

ContractionInc. vascularPermeability 

Integumentary S/Sx

O2 administrationranitidine

epinephrine0.9% NaCl IV  methylprednisolone diphenhydramine

Ineffective respiratory function r/t excessive

secretions asmanifested by stridor

Decreased cardiacoutput related todecreased venous

return as evidenced by dyspnea,

decreasedperipheral pulses

and peripheralcyanosis

Ineffective tissueperfusion related to

mismatch of 

 ventilation with blood flow asevidenced by 

altered mentalstatus and

peripheral cyanosis

Risk for impairedskin integrity 

related toimmunologic

factors asevidenced by hives,

pruritus anderythema

 Activity intolerancerelated to oxygenationimbalances of supply 

and demand ascharacterized by chest

pain and dyspnea

Page 16: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 16/26

Nursing Care InterventionsA. Independent 

Insert an I.V. line for giving emergency drugs and volume expanders. 

Continually reassure the patient and explain all tests and treatments toreduce fear and anxiety. 

Monitored V/S regularly including pain episodes and O2 saturation 

Auscultated lung fields and heart tones & notified MROD for significant

changes 

Assessed LOC & orientation 

Checked peripheral pulses & observed extremities for color, capillary refill,

& sensation 

Page 17: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 17/26

Nursing Care InterventionsA. Independent

Kept environment quiet & calm, provided relaxing techniques

Ensured physical rest with passive exercises 

Provided information to patient & SOs regarding disease process,

diagnostics, medications & interventions 

Observe for complications associated with anaphylaxis, such as vascular 

collapse and acute respiratory insufficiency or obstruction. 

Closely observe a patient with known allergies for anaphylaxis when giving

a drug with high anaphylactic potential. 

Page 18: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 18/26

Nursing Care Interventions

B. Dependent 

Administered medications, and O2 therapy as

 prescribed and evaluated body response accordingly. 

Rapidly infuse I.V. fluids to fill vasodilated

circulatory system and raise blood pressure. Titrate

vasopressors based on blood pressure response asordered. 

Administered O2 as prescribed. If hypoxia continues,

 prepare to help insert an artificial airway. 

Page 19: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 19/26

Ecologic Model

Anaphylactic Shock 

Idiopathic:

Ibuprofen

(NSAIDs) 

Hypertension

Medication:

Lisinopril Family History of 

Bronchial Asthma 

Anaphylaxis MR. E 

Unresolved 

Page 20: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 20/26

Evidenced-Based Practice

Title:

 A Role for Platelet-Activating Factor in Anaphylaxis

Purpose:

To evaluate the relationship between PAF, PAFacetylhydrolase, and the severity of anaphylaxis,patients with acute allergic reactions were studiedprospectively at the time of presentation to theemergency department of a university teachinghospital.

Page 21: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 21/26

Evidenced-Based Practice

Clinical Question:

• Does Platelet activating factor (PAF) levels andPlatelet activating factor acetylhydrolase activity determine the severity of anaphylaxis?

• Does Platelet activating factor (PAF) levels and

Platelet activating factor acetylhydrolase activity determine the risk of an individual foranaphylactic shock?

Page 22: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 22/26

Evidenced-Based Practice

Summary & Conclusion:

• The results of the study implicates that therelationship between PAF acetylhydrlase and theseverity of anaphylaxis is inversely proportional.

• The higher the individual’s level of PAF

acetylhydrolase the lower the severity of his/heranaphylaxis is.

• PAF acetylhydrolase deficiency is anindependent risk factor for fatal anaphylaxis

Page 23: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 23/26

Evidenced-Based Practice

Significance:

These data provide the rationale for thedevelopment of drugs to selectively block theactions of PAF, both as rescue therapy in cases of acute anaphylaxis and potentially as long-term

preventive treatment for those at highest risk forfatal anaphylaxis.

Page 24: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 24/26

Theoretical Basis of Care

Orem’s Self -Care Deficit Theory 

Page 25: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 25/26

Ethico-Moral & Legal Issues

Ethico-MoralPrinciples:▫  Autonomy 

▫ Nonmalifecence

▫ Beneficence

▫ Justice

▫  Veracity 

Legal Responsibilities:▫ Patient’s advocate 

▫  Administeringmedication

▫ Informed consent

Page 26: Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

7/28/2019 Unrecognized Pre-Hospital Anaphylactic Hypersensitivity

http://slidepdf.com/reader/full/unrecognized-pre-hospital-anaphylactic-hypersensitivity 26/26

Thank You!!!